🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted steps to address household expense pressures" in the upcoming Budget.

In comments to the BBC, she emphasized that curbing price rises is a joint task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this year and next.

Possible Utility Cost Measures

It is understood the administration could intervene to bring down utility costs, for instance by slashing the current 5% level of value-added tax charged on energy supplies.

An additional possibility is to lower some of the policy costs presently added to bills.

Fiscal Limitations and Expert Expectations

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such actions.

The consensus from the majority of analysts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, estimates indicated there was a £22bn deficit for the chancellor to address, which is at the more modest range of forecasts.

"It is a collective job between the Bank of England and the government to bear down further on some of the drivers of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and Global Issues

While much of the focus has been on probable tax rises, the Treasury chief said the latest data from the OBR had not changed her pledge to manifesto promises not to increase rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing international and commercial concerns for the fiscal tax moves, likely to be targeted on those "most able to pay."

Global Trade Disputes

Commenting on concerns about the UK's commercial links with China she said: "Our security interests invariably are paramount."

Last week's statement by China to increase export controls on rare earths and other resources that are essential for high-technology manufacturing led American leader the US President to threaten an additional 100% tariff on goods from the Asian country, increasing the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief described China's action "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the US offer to join its battle with the Asian nation, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the action was "damaging for the world economy and generates further headwinds."

"In my view there are sectors where we should address Chinese policies, but there are also significant chances to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that equilibrium right."

The chancellor also affirmed she was collaborating with international partners "regarding our own critical minerals approach, so that we are reduced dependence."

NHS Medicine Costs and Investment

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could increase as a result of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning projects in the United Kingdom, with several attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the health service spends on drugs would have to rise to prevent businesses and pharmaceutical investment departing from the UK.

The Chancellor informed the BBC: "It has been observed because of the cost structure, that clinical trials, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."

"We want to ensure that individuals getting treatment from the NHS are able to receive the best life-saving medicines in the world. And so we are examining all of that, and... looking to obtain more capital into Britain."